MoneyWorks4Me

Dr. Lal Path Labs informs about investor meet

19 Nov 2021 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal Path Labs has informed that it enclosed details of the proposed schedule of Analyst/ Institutional Investor meeting(s). Dates of the aforesaid meeting/ call are subject to change due to exigencies on the part of Investor/ Company. No Unpublished Price Sensitive Information will be shared during the meetings.

The above information is a part of company’s filings submitted to BSE.

Peers